elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Synthetic lethality
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Synthetic lethality
RIS
0.001
(Research Intensity Score)
Papers
77
Top papers
Metabolic regulation of homologous recombination repair by MRE11 lactylation
2023 · 489 citations
Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics
2025 · 61 citations
A new wave of innovations within the DNA damage response
2023 · 136 citations
BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality
2023 · 135 citations
Targeting oncogenic Myc as a strategy for cancer treatment
2018 · 851 citations
Newest papers
Chemoresistance in ovarian cancer (I)
2026 · 11 citations
Low-dose X-ray-activated radiodynamic therapy via a lutetium-coordinated nanoplatform synergizing PARP inhibition and ferroptosis
2026 · 3 citations
Restoration of chemosensitivity to drug resistant breast cancer cells through peptide activation of the anaphase promoting complex
2026 · 1 citations
Multimodal interrogation establishes the AAA+ ATPase RUVBL1 as a prognostic driver and tractable dependency in malignant pleural mesothelioma
2026
Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies
2026
A sample from the 77 top papers behind Synthetic lethality.
Create a free account to browse them all →
Synthetic lethality's history
Research intensity over time
Explore Synthetic lethality's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Synthetic lethality's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link